481 related articles for article (PubMed ID: 31990275)
1. Clinical significance of slightly reduced von Willebrand factor activity.
Bykowska K; Ceglarek B
Pol Arch Intern Med; 2020 Mar; 130(3):225-231. PubMed ID: 31990275
[TBL] [Abstract][Full Text] [Related]
2. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
[TBL] [Abstract][Full Text] [Related]
3. Laboratory diagnosis and molecular classification of von Willebrand disease.
Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of inherited von Willebrand disease: a clinical perspective.
Federici AB
Semin Thromb Hemost; 2006 Sep; 32(6):555-65. PubMed ID: 16977566
[TBL] [Abstract][Full Text] [Related]
5. Characterization, classification, and treatment of von Willebrand diseases: a critical appraisal of the literature and personal experiences.
Michiels JJ; Gadisseur A; Budde U; Berneman Z; van der Planken M; Schroyens W; van de Velde A; van Vliet H
Semin Thromb Hemost; 2005 Nov; 31(5):577-601. PubMed ID: 16276467
[TBL] [Abstract][Full Text] [Related]
6. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
Clin Appl Thromb Hemost; 2006 Jul; 12(3):277-95. PubMed ID: 16959681
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and management of von Willebrand disease in Australia.
Favaloro EJ; Bonar R; Favaloro J; Koutts J
Semin Thromb Hemost; 2011 Jul; 37(5):542-54. PubMed ID: 22102198
[TBL] [Abstract][Full Text] [Related]
8. Type 1 VWD classification revisited: novel insights from combined analysis of the LoVIC and WiN studies.
Atiq F; Blok R; van Kwawegen CB; Doherty D; Lavin M; van der Bom JG; O'Connell NM; de Meris J; Ryan K; Schols SEM; Byrne M; Heubel-Moenen FCJI; van Galen KPM; Preston RJS; Cnossen MH; Fijnvandraat K; Baker RI; Meijer K; James P; Di Paola J; Eikenboom J; Leebeek FWG; O'Donnell JS
Blood; 2024 Apr; 143(14):1414-1424. PubMed ID: 38142407
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of von Willebrand disease type 2N: a simplified method for measurement of factor VIII binding to von Willebrand factor.
Miller CH; Kelley L; Green D
Am J Hematol; 1998 Aug; 58(4):311-8. PubMed ID: 9692396
[TBL] [Abstract][Full Text] [Related]
10. Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States.
Flood VH; Christopherson PA; Gill JC; Friedman KD; Haberichter SL; Bellissimo DB; Udani RA; Dasgupta M; Hoffmann RG; Ragni MV; Shapiro AD; Lusher JM; Lentz SR; Abshire TC; Leissinger C; Hoots WK; Manco-Johnson MJ; Gruppo RA; Boggio LN; Montgomery KT; Goodeve AC; James PD; Lillicrap D; Peake IR; Montgomery RR
Blood; 2016 May; 127(20):2481-8. PubMed ID: 26862110
[TBL] [Abstract][Full Text] [Related]
11. Dominant von Willebrand disease type 2A groups I and II due to missense mutations in the A2 domain of the von Willebrand factor gene: diagnosis and management.
Michiels JJ; van Vliet HH
Acta Haematol; 2009; 121(2-3):154-66. PubMed ID: 19506362
[TBL] [Abstract][Full Text] [Related]
12. Von Willebrand's disease: case report and review of literature.
Echahdi H; El Hasbaoui B; El Khorassani M; Agadr A; Khattab M
Pan Afr Med J; 2017; 27():147. PubMed ID: 28904675
[TBL] [Abstract][Full Text] [Related]
13. Classification and characterization of hereditary types 2A, 2B, 2C, 2D, 2E, 2M, 2N, and 2U (unclassifiable) von Willebrand disease.
Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
Clin Appl Thromb Hemost; 2006 Oct; 12(4):397-420. PubMed ID: 17000885
[TBL] [Abstract][Full Text] [Related]
14. A Laboratory Phenotype/Genotype Correlation of 1167 French Patients From 670 Families With von Willebrand Disease: A New Epidemiologic Picture.
Veyradier A; Boisseau P; Fressinaud E; Caron C; Ternisien C; Giraud M; Zawadzki C; Trossaert M; Itzhar-Baïkian N; Dreyfus M; d'Oiron R; Borel-Derlon A; Susen S; Bezieau S; Denis CV; Goudemand J;
Medicine (Baltimore); 2016 Mar; 95(11):e3038. PubMed ID: 26986123
[TBL] [Abstract][Full Text] [Related]
15. How we diagnose 2M von Willebrand disease (VWD): Use of a strategic algorithmic approach to distinguish 2M VWD from other VWD types.
Favaloro EJ; Mohammed S; Vong R; Oliver S; Brennan Y; Favaloro JW; Curnow J
Haemophilia; 2021 Jan; 27(1):137-148. PubMed ID: 33215808
[TBL] [Abstract][Full Text] [Related]
16. Quantitative impact of using different criteria for the laboratory diagnosis of type 1 von Willebrand disease.
Quiroga T; Goycoolea M; Belmont S; Panes O; Aranda E; Zúñiga P; Pereira J; Mezzano D
J Thromb Haemost; 2014 Aug; 12(8):1238-43. PubMed ID: 24796601
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and management of adult patients with von Willebrand disease in South Australia.
Rodgers SE; Lloyd JV; Mangos HM; Duncan EM; McRae SJ
Semin Thromb Hemost; 2011 Jul; 37(5):535-41. PubMed ID: 22102197
[TBL] [Abstract][Full Text] [Related]
18. Bleeding tendency and efficacy of anti-haemorrhagic treatments in patients with type 1 von Willebrand disease and increased von Willebrand factor clearance.
Castaman G; Tosetto A; Federici AB; Rodeghiero F
Thromb Haemost; 2011 Apr; 105(4):647-54. PubMed ID: 21264446
[TBL] [Abstract][Full Text] [Related]
19. Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1VWD).
Tosetto A; Rodeghiero F; Castaman G; Bernardi M; Bertoncello K; Goodeve A; Federici AB; Batlle J; Meyer D; Mazurier C; Goudemand J; Eikenboom J; Schneppenheim R; Budde U; Ingerslev J; Vorlova Z; Habart D; Holmberg L; Lethagen S; Pasi J; Hill F; Peake I
J Thromb Haemost; 2007 Apr; 5(4):715-21. PubMed ID: 17408405
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
